Objectives: This study was conducted to investigate the clinical significance of Slit2 and Robo1 expression in prognosis of patients with brain gliomas.

Methods: Human brain tissue samples were collected from normal glial tissues (control), low- and high-grade glioma tissues. Slit2 and Robo1 expression levels in cells were assessed by an immunohistochemistry (IHC), and population of the Slit2- and Robo1-presenting patients was examined. The Slit2 and Robo1 mRNA expression levels in three types of the brain cells was determined by RT-PCR.

Results: Slit2 cell counts were decreased with increased Robo1 cells in the low-grade and high-grade glioma tissues as compared to the control. The percentage of cells expressing Slit2 decreased from the control to the high-grade glioma and the percentage of cells expressing Robo1 in low- and high-grade gliomas was increased as compared to the control (P < 0.01). The decrease in the Slit2 mRNA expression was associated with the increase in the Robo1 mRNA expression in the low- and high-grade gliomas (P < 0.01 or 0.05). Survival time for patients with Slit2/Robo1 gliomas was shorter than patients with Slit2/Robo1 gliomas in the investigated cohorts (P < 0.01).

Conclusion: Slit2 and Robo1 expression levels serve as a biomarker with utility in grading gliomas as well as predicting patient survival. The change in Slit2 expression is more reliable and effective than Robo1 expression in predicting a poor prognosis of brain glioma patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suronc.2016.09.003DOI Listing

Publication Analysis

Top Keywords

slit2 robo1
16
robo1 expression
12
high-grade glioma
12
low- high-grade
8
glioma tissues
8
expression levels
8
compared control
8
percentage cells
8
cells expressing
8
slit2
6

Similar Publications

Roundabout (ROBO) 1 and 2 are transmembrane receptors that bind secreted SLIT ligands through their extracellular domains (ECDs) and signal through their cytoplasmic domains to modulate the cytoskeleton and regulate cell migration, adhesion, and proliferation. SLIT-ROBO signaling regulates pathological ocular neovascularization, which is a major cause of vision loss worldwide, but pharmacological tools to prevent SLIT-ROBO signaling are lacking. Here, we developed human monoclonal antibodies (mAbs) against the ROBO1 and ROBO2 ECDs.

View Article and Find Full Text PDF

Trillium tschonoskii rhizome saponin improves spatial learning and memory by enhancing neurovascular restorative in ischemic rats.

Phytomedicine

December 2024

School of Traditional Chinese Medicine, Capital Medical University, Beijing, China; Beijing Key Lab of TCM Collateral Disease Theory Research, Beijing, China. Electronic address:

Article Synopsis
  • Trillium tschonoskii rhizome saponins (TSTT) are traditionally used in folk medicine for conditions like traumatic injury and cancer, but the specific mechanisms behind its neurovascular restorative effects after ischemia are not fully understood.
  • The purpose of the study was to investigate the effectiveness of TSTT in promoting recovery in ischemic rats, particularly regarding neurovascular repair and improvements in spatial learning and memory.
  • Experimental methods included creating a permanent ischemia model in rats, administering various doses of TSTT, and using MRI, behavioral tests, and histopathological techniques to assess brain health and neuronal repair, with results showing that TSTT reduced infarction and improved brain structure and function compared to untreated controls
View Article and Find Full Text PDF
Article Synopsis
  • SLITs are proteins that act as ligands for ROBO receptors, which are important for cell signaling.
  • Research indicates that ROBO1 helps mammary cells differentiate and produce milk by blocking Notch signaling.
  • In experiments, knockout mice lacking SLIT2 and SLIT3 showed better development of milk-producing cells and higher milk production, suggesting that SLITs inhibit this process by interfering with ROBO1.
View Article and Find Full Text PDF

TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease.

Curr Opin Endocrinol Diabetes Obes

October 2024

Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Purpose Of Review: Evolving understanding of thyroid eye disease (TED) has led to rapidly advancing therapeutic options. Most new treatments under development or recently available to patients are predicated on insights into disease mechanism.

Recent Findings: TED, a disfiguring process, involves inflammation and remodeling of the connective tissues around the eye.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!